Why Sequestration Could Really Hurt Long-Term Research
The across-the-board U.S. budget cuts scheduled to take effect on March 1, known as sequestration, will have ripple effects that hurt scientific and health research for years to come, the heads of two federal research agencies said this week.
In a note distributed to research institutions, the National Science Foundation, which awards research grants on topics like climate change, materials science, and computing, anticipates it will issue about 1,000 fewer new grants than it had expect this fiscal year. And Francis Collins, the director of the National Institutes of Health, said the $1.5 billion cut from its $30 billion budget would slow research in diseases, specifically calling out a push to develop a universal influenza vaccine—”a project that is going extremely well,” he told reporters.
Collins said his greatest concern is the effect on young scientists, because the NIH’s training grants would be cut. He noted the psychological effects to their dreams and visions, not just the monetary ones.
This may sound mushy to someone not familiar with the world of research. But for students in or hoping to enter doctoral programs, it is a rough and long path to a career in science, one that many can’t sustain even in normal times. If a funding setback, a grant that should have come through, or the general uncertainy about the funding future is demoralizing for seasoned researchers, it has got to be worse for those in the early stages of their careers. Fewer grants means fewer opportunities and a leakier “pipeline” of scientific talent—and that, in the end, may be the worst effect of the series of budget crises that politics has left us.
Keep Reading
Most Popular
How Rust went from a side project to the world’s most-loved programming language
For decades, coders wrote critical systems in C and C++. Now they turn to Rust.
The inside story of how ChatGPT was built from the people who made it
Exclusive conversations that take us behind the scenes of a cultural phenomenon.
Design thinking was supposed to fix the world. Where did it go wrong?
An approach that promised to democratize design may have done the opposite.
Sam Altman invested $180 million into a company trying to delay death
Can anti-aging breakthroughs add 10 healthy years to the human life span? The CEO of OpenAI is paying to find out.
Stay connected
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.